Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Free Cash Flow Generation Index
Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Free Cash Flow Generation Index of 0.77x as of September 2025. Free cash flow of CN¥86.32 Million represents 1% of operating cash flow (CN¥112.12 Million). Read total liabilities of Jilin Aodong Pharmaceutical Group Co Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jilin Aodong Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Jilin Aodong Pharmaceutical Group Co Ltd across 26 annual periods. Explore 000623 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Jilin Aodong Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year Free Cash Flow Generation Index for Jilin Aodong Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see Jilin Aodong Pharmaceutical Group Co Ltd (000623) total market value.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | CN¥143.81 Million | CN¥272.26 Million | CN¥128.45 Million | ▲ +114.6% |
| 2024 | -3.61x | CN¥-214.50 Million | CN¥59.48 Million | CN¥273.98 Million | ▲ +30.2% |
| 2023 | -5.16x | CN¥-351.46 Million | CN¥68.06 Million | CN¥419.52 Million | ▼ -1531.6% |
| 2022 | 0.36x | CN¥152.89 Million | CN¥423.86 Million | CN¥270.97 Million | ▲ +915.0% |
| 2021 | 0.04x | CN¥11.54 Million | CN¥324.85 Million | CN¥313.30 Million | ▼ -91.5% |
| 2020 | 0.42x | CN¥163.02 Million | CN¥390.41 Million | CN¥227.38 Million | ▲ +0.9% |
| 2019 | 0.41x | CN¥157.06 Million | CN¥379.46 Million | CN¥222.40 Million | ▲ +40.6% |
| 2018 | 0.29x | CN¥102.33 Million | CN¥347.64 Million | CN¥245.30 Million | ▼ -56.2% |
| 2017 | 0.67x | CN¥172.56 Million | CN¥256.49 Million | CN¥83.93 Million | ▲ +27.8% |
| 2016 | 0.53x | CN¥175.79 Million | CN¥333.81 Million | CN¥158.03 Million | ▲ +279.0% |
| 2015 | 0.14x | CN¥53.92 Million | CN¥388.03 Million | CN¥334.11 Million | ▲ +135.5% |
| 2014 | -0.39x | CN¥-113.18 Million | CN¥288.83 Million | CN¥402.01 Million | ▲ +26.8% |
| 2013 | -0.54x | CN¥-107.79 Million | CN¥201.22 Million | CN¥309.01 Million | ▼ -168.3% |
| 2012 | -0.20x | CN¥-54.40 Million | CN¥272.40 Million | CN¥326.80 Million | ▲ +93.8% |
| 2011 | -3.23x | CN¥-349.42 Million | CN¥108.30 Million | CN¥457.72 Million | ▼ -2628.9% |
| 2010 | 0.13x | CN¥22.23 Million | CN¥174.22 Million | CN¥152.00 Million | ▼ -84.6% |
| 2009 | 0.83x | CN¥176.51 Million | CN¥213.03 Million | CN¥36.51 Million | ▼ -4.3% |
| 2008 | 0.87x | CN¥203.51 Million | CN¥235.03 Million | CN¥31.52 Million | ▼ -3.6% |
| 2007 | 0.90x | CN¥345.45 Million | CN¥384.69 Million | CN¥39.24 Million | ▲ +28.7% |
| 2006 | 0.70x | CN¥131.12 Million | CN¥187.99 Million | CN¥56.87 Million | ▲ +18.0% |
| 2005 | 0.59x | CN¥80.57 Million | CN¥136.26 Million | CN¥55.68 Million | ▼ -25.0% |
| 2004 | 0.79x | CN¥172.35 Million | CN¥218.53 Million | CN¥46.19 Million | ▲ +108.8% |
| 2003 | 0.38x | CN¥55.76 Million | CN¥147.65 Million | CN¥91.89 Million | ▲ +176.4% |
| 2001 | -0.49x | CN¥-68.61 Million | CN¥138.76 Million | CN¥207.37 Million | ▲ +56.1% |
| 2000 | -1.13x | CN¥-86.86 Million | CN¥77.04 Million | CN¥163.90 Million | ▼ -413.2% |
| 1999 | 0.36x | CN¥39.66 Million | CN¥110.18 Million | CN¥70.52 Million | — |